# Why It’s Illegal to Call a Drug “Stroebenazoline”

Source: https://www.youtube.com/watch?v=lX_SnVQXC-A
Recap page: https://rapidrecap.app/video/lX_SnVQXC-A
Generated: 2026-08-21T22:33:04.009+00:00

---
## The Gist

Drug names are strictly regulated to prevent medical errors, requiring unique names that are easily pronounceable and distinct from existing pharmaceuticals. Proposed names undergo rigorous computer analysis through systems like POCA to ensure they do not sound or look too similar to established medications.

## Quick Overview

Pharmaceutical drug names are subjected to thousands of rules, international approvals, and computerized phonetic analysis to prevent catastrophic medical errors caused by look-alike or sound-alike medications. The naming process requires navigating organizations like the USAN Council and the WHO, ensuring generic and proprietary names remain distinct, short, pronounceable, and free from misleading implications or prohibited character combinations.

**Key Points:**
- Medication naming errors cause at least one death daily and roughly 1.3 million injuries annually in the United States alone.
- A drug must go through three distinct naming stages: a research compound name, an International Nonproprietary Name, and a proprietary brand name.
- Generic drug names consist of a prefix and a suffix stem, with roughly 600 active stems defining what the drug actually does medically.
- Generic drug names are restricted to a maximum of five syllables and must not begin with silent or non-existent letters in foreign languages.
- Proposed proprietary brand names cannot use more than three consecutive letters of their corresponding generic name stem.
- Drug naming agencies use the Phonetic and Orthographic Computer Analysis tool to score name similarity against all existing medications on record.
- Pharmaceutical companies often pay consulting agencies up to half a million dollars to create and test thousands of potential drug names before one successfully passes regulation.

![Screenshot at 03:48: The Phonetic and Orthographic Computer Analysis tool evaluates how closely a proposed drug name matches existing medications.](https://ss.rapidrecap.app/screens/lX_SnVQXC-A/00-03-48.jpg)

**Context:** Naming prescription drugs is not merely a branding exercise, but a rigorous safety protocol overseen by national and international bodies to protect patients from fatal medication errors.

## Detailed Analysis

Drug nomenclature involves strict linguistic and structural limitations enforced by organizations such as the United States Adopted Names Council and the World Health Organization. Pharmaceutical companies spend immense resources and millions of dollars developing thousands of candidate names that must pass rigorous checks on syllable counts, phonetic distinctiveness, and orthographic dissimilarity. Names that fail to meet criteria, such as having too many syllables, utilizing misleading prefixes, or resembling existing medications too closely, are rejected to safeguard global healthcare systems against dangerous medication dispensing errors.

### The Three Phases of Drug Naming

Every prescription medication passes through three distinct naming stages during its lifecycle from research to market.

- The compound name used in the research phase consists of a company identifier followed by a string of numbers and letters.
- The generic name provides a standardized universal identifier for the active pharmaceutical ingredient, featuring a defined suffix stem.
- The proprietary brand name is created by the manufacturer for commercial marketing once regulatory approval is secured.

![Screenshot at 00:48: The three required categories of drug names span compound, generic, and proprietary designations.](https://ss.rapidrecap.app/screens/lX_SnVQXC-A/00-00-48.jpg)

### Generic Drug Name Stems and Rules

Generic names follow strict linguistic architectures to indicate a drug class while remaining distinct across languages.

- Generic names combine a custom prefix with a standardized suffix stem that denotes the pharmacological action of the drug.
- There are roughly 600 active drug stems, such as conazole for antifungals and triptylin for antidepressants.
- Generic names must contain no more than five syllables and cannot start with silent or non-existent letters in non-English languages.

![Screenshot at 01:44: Standardized generic stems clearly identify the therapeutic category of each medication.](https://ss.rapidrecap.app/screens/lX_SnVQXC-A/00-01-44.jpg)

### Proprietary Name Restrictions and POCA

Brand names must avoid creating dangerous confusion with existing medications on the global market.

- Proprietary names cannot share more than three consecutive letters with their generic name stem.
- The Food and Drug Administration uses Phonetic and Orthographic Computer Analysis to generate a similarity score against all registered drugs.
- A high similarity score requires companies to adjust their brand name within a four-month objection window before final approval.

![Screenshot at 03:52: The POCA software calculates exact numerical similarity metrics between proposed and existing drug names.](https://ss.rapidrecap.app/screens/lX_SnVQXC-A/00-03-52.jpg)